Antigen presentation by Hodgkin's disease cells.

Area of Science:

• Immunology
• Cell Biology
• Oncology

Background:

• Hodgkin's disease is characterized by Reed-Sternberg cells.
• The L428 cell line is a long-term culture of these cells.
• Understanding their function is crucial for cancer research.

Purpose of the Study:

• To characterize the antigen-presenting capabilities of the L428 cell line.
• To investigate the expression of human immune response genes in L428 cells.
• To determine if L428 cells can function as antigen-presenting cells in T cell activation.

Main Methods:

• Culturing the L428 tumor cell line.
• Assessing cell surface antigen expression (HLA-DR, DS, SB).
• Conducting T cell proliferation assays with tetanus toxoid and L428 cells.
• Utilizing T cell lines with defined HLA-DR types.
• Blocking assays with anti-HLA-DR antibodies.

Main Results:

• L428 cells express all known subclasses of human immune response genes within the major histocompatibility complex.
• L428 cells successfully presented soluble antigen to T cells in a genetically restricted manner.
• T cell proliferation was observed when L428 cells presented tetanus toxoid to compatible T cells.
• No T cell proliferation occurred when L428 cells were presented to incompatible T cell lines.
• T cell proliferation was inhibited by anti-HLA-DR antibodies.

Conclusions:

• The L428 cell line functionally mimics normal antigen-presenting cells.
• Hodgkin's disease can be functionally classified as a malignancy of antigen-presenting cells.
• These findings provide insights into the immunological basis of Hodgkin's disease.